Method Development

AXYS’s industry-leading product development team focus entirely on method development for new contaminants and new matrices. AXYS’s expertise has been selected to develop analytical procedures for several regulatory bodies, focused on detecting some of the most difficult trace analyses of complex matrices.

Organochlorine Legacy Compounds

• Validation of Method 1668A (PCBs by HRMS) for U.S. EPA including serum and blood matrices

 

Emerging Contaminants

• Development of Method 1614A (PBDEs by HRMS) for U.S. EPA including serum and blood matrices
• Development of Method for Pharmaceutical and Personal Care Products (42 parameters) by LC/MS/MS (Water and Biosolids Matrix)
• Development of Method for Sterols (22 parameters) by LR GC/MS (Water and Biosolids Matrix)
• Development of Method for Parabens in Serum by LC/MS/MS for a North American NGO organization

 

Specialty Analysis

• Development of Method for Acid Extractable Herbicides (8 parameters) by HRMS (Water and BioSolid Matrices) for Environment Canada
• Development of Method for Multi Residue Pesticides (79 parameters) by HRMS (Water and BioSolid Matrices)
• Development of Method for Pyrethroid Pesticides (19 parameters) by HRMS (Water and Biosolid Matrices)
• Development of Method for combined Bisphenol A and Mono Phthalate Esters in Urine for U.S. Health Regulatory Agency by LC/MS/MS (current project)
• Development of Method for Triclosan in Serum by LC/MS/MS for U.S. a North American NGO organization

Return to Top